Compare ADMA & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | HHH |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.9B |
| IPO Year | 2012 | 2023 |
| Metric | ADMA | HHH |
|---|---|---|
| Price | $10.60 | $62.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $25.67 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 4.9M | 355.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.60 | ★ 2.21 |
| Revenue | $42,219,783.00 | ★ $1,474,892,000.00 |
| Revenue This Year | $27.46 | $14.04 |
| Revenue Next Year | $22.11 | N/A |
| P/E Ratio | ★ $18.18 | $28.98 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $61.01 |
| 52 Week High | $24.17 | $91.07 |
| Indicator | ADMA | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 36.99 |
| Support Level | $7.21 | $61.84 |
| Resistance Level | $16.48 | $65.56 |
| Average True Range (ATR) | 0.47 | 1.53 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 55.40 | 2.30 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.